Semaglutide Shortage: Current Status by Strength and What to Do

No. The shortage for semaglutide injections was resolved on February 21, 2025. The older Rybelsus tablets are now being discontinued.

Shortage: Resolved
Lowest self-pay: $149 a month
Prescription: Required

A quick look at Wegovy

How long it remains in the body

Its half-life is about 1 week: after 7 d half is gone, and after five half-lives (35 d) about 3% is left.

Weight loss in its main trial

In STEP 1 over 68 weeks, people lost 14.9% of body weight, compared with 2.4% on placebo.

Cost over time

Monthly prices in US dollars, covering list price and self-pay offers, with each one taken from the maker's price page.

Sources: FDA label (DailyMed), healthsystemtracker.org, prnewswire.com 1 2.

Every legal way to get semaglutide, ranked

Ways to get it, cheapest first
Route	Who it is for	What you pay
Ozempic: Novo Nordisk PAP	Household income: 200% or less of the federal poverty level	Free if approved
Ozempic: Go through your doctor and use insurance with the savings card	Commercial insurance that covers it	For up to 3 months, you may pay as little as $25 each month
Wegovy: Get it through your doctor, using insurance with the savings card	Commercial insurance that covers it	As little as $25 a month
Rybelsus: Go through your doctor and use insurance with the savings card	Commercial insurance that covers it	A fill of 1, 2 or 3 months may cost as little as $25
Ozempic: NovoCare Pharmacy: Ozempic pill (from 1.5 mg)	Anyone with a prescription, no insurance needed	$149 a month
Ozempic: GoodRx: GoodRx lowest price	Cash at the pharmacy counter	$149 a month
Wegovy: NovoCare Pharmacy: Wegovy pill 1.5 mg	Anyone with a prescription, no insurance needed	$149 a month
Wegovy: TrumpRx listing (pill, starting)	Self-pay only	$149 a month
Wegovy: Costco Pharmacy: member price	Cash at the pharmacy counter	$149 a month

Prices checked November 2026. Each price links to the page it comes from.

Sources: Novo Nordisk pricing, NovoCare, TrumpRx, rx.costco.com.

Who qualifies

All GLP-1 products sold in the US require a prescription. A prescriber writes it for one of the approved uses on the label:

Ozempic: It lowers blood sugar in adults with type 2 diabetes when used with diet and exercise.
Ozempic: For adults who have both type 2 diabetes and heart disease, it reduces the odds of a heart attack, a stroke, or heart-related death.
Wegovy: It lowers the risk of heart attack, stroke or heart-related death in adults with heart disease who also have obesity or are overweight (injection and tablets).
Wegovy supports weight loss and helps keep weight off over the long term for adults and children 12 and older with obesity, alongside diet and activity.
Rybelsus: It lowers blood sugar in adults with type 2 diabetes when used with diet and exercise.
Stroke, heart attack and heart-related death become less likely when high-risk adults with type 2 diabetes take Rybelsus.

Source: FDA label (DailyMed).

Telehealth options compared

Telehealth programs for semaglutide
Program	Medicine option	Medicine price	Membership	All in
WeightWatchers Med+	Wegovy pill (self-pay)	$149 a month	$74 a month	$223 a month
WeightWatchers Med+	Ozempic injectable pen (self-pay)	$199 a month	$74 a month	$273 a month
Ro	Wegovy pill, starting dose	$149 a month	$149 a month	$298 a month
Hims & Hers	Wegovy pill	$149 a month	$149 a month after first month	$298 a month
Hims & Hers	Ozempic pen	$199 a month	$149 a month after first month	$348 a month
Sesame (Success by Sesame)	Wegovy or Ozempic pen, after intro months	$349 a month	$59 a month	$408 a month
Ro	Wegovy pen, 1 mg to 2.4 mg	$349 a month	$149 a month	$498 a month
Mochi Health	Compounded semaglutide (not FDA approved)	$60 a month	$79 a month after free first month	$139 a month
Henry Meds	Compounded semaglutide taken under the tongue, in tablets or drops, is not FDA approved for use	$179 a month	Not listed	Included
Noom Med	Microdose GLP-1Rx Program (compounded) (not FDA approved)	once 4 weeks have passed, $179 a month, billed quarterly	Not listed	Included
Noom Med	GLP-1Rx Program (compounded semaglutide) (not FDA approved)	once 4 weeks have passed, $249 a month, billed quarterly	Not listed	Included
Found	Compounded GLP-1 plan (not FDA approved)	$99 a month	$169 a month cash	$268 a month
Henry Meds	Compounded semaglutide (weekly injection) (not FDA approved)	$297 a month	Not listed	Included

Every program posts these prices on its own pricing page. We do not make money from them.

Sources: weightwatchers.com, ro.co, hims.com, sesamecare.com.

Shortage status

The shortage for semaglutide injections was resolved on February 21, 2025. The older Rybelsus tablets are now being discontinued.

Semaglutide supply for each product
Product	FDA status	Availability
Rybelsus tablet 3 mg, 7 mg, 14 mg	To Be Discontinued	Replaced by Ozempic (semaglutide) tablets

First appeared on the FDA shortage list: March 2022
Shortage resolved: February 21, 2025
As of April 22, 2025, state pharmacies had to stop making compounded copies
Outsourcing facilities had to stop: May 22, 2025

Sources: FDA, api.fda.gov.

Scam signals

No prescription needed: skipping it means the seller holds no pharmacy license in the US.
A brand price that falls well below the manufacturer's charge: the lowest self-pay price for the brand is $149 a month.
When sellers market compounded drugs as the brand, FDA has not approved them, so none is Ozempic, Wegovy, Mounjaro or Zepbound.
The sodium and acetate salts of semaglutide are different from the active ingredient in drugs approved by FDA.
Telling buyers a product matches the brand: the FDA sent 30 warning letters to telehealth companies about misleading claims.
Harm reports: 990 adverse event reports linked to compounded semaglutide appear on the FDA list.
A monthly price that leaves out the drug: the FTC acted against one program over this; see NextMed review.

Sources: Novo Nordisk pricing, NovoCare, TrumpRx, rx.costco.com.

Find it in your state

Hims & Hers: Not all 50 states are covered
Noom Med: It does not serve some of the 50 states
NovoCare Pharmacy: Delivery reaches all 50 states, as well as DC, Puerto Rico

The route changes most under Medicaid rules. Medicaid rules matter most when you choose your route. today, 10 Medicaid programs across the states cover GLP-1s for weight loss. Select your state to find its drug list and prior authorization rules:

Sources: hims.com, noom.com, NovoCare.